Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- N/A
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Selinexor (KPT- 330), Lenalidomide, & Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR
- Status
- UNKNOWN
- Phase
- N/A
Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer
- Status
- TERMINATED
- Phase
- NA
Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
- Status
- COMPLETED
- Phase
- PHASE2
A Study of VLX1570 and Dexamethasone in Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Expanded Access Treatment Protocol CA204-143
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Kidney Therapy for Free Light Chain Removal in Patients With Multiple Myeloma & Cast Nephropathy
- Status
- COMPLETED
- Phase
- N/A
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year
- Status
- COMPLETED
- Phase
- PHASE2
Selinexor and Backbone Treatments of Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Selinexor Treatment of Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE2